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ABSTRACT 
Current designs for small molecule theranostics, which serve both a diagnostic and
therapeutic role, often involve dyes linked to therapeutic agents through a cleavable,
traceless linker. In order to facilitate the separation of the dye from the therapeutic in
response to a biological or chemical stimulus, linkers must incorporate elements of
molecular logic, increasing their complexity and the overall bulk of the small
molecule theranostic. By combining the self-immolative molecular logic of the linker
into the structure of the dye itself, we hope to create a series of smaller, more atom-
economical theranostics. Rhodamine dyes, which naturally possess aromatic rings
with highly-tunable electron density, are promising candidates in this regard. Toward
this end, we have synthesized a substituted rhodamine-precursor in 4 steps with a
25% overall yield, utilizing a highly-optimized radical bromination. Upon completion
of the rhodamine scaffold, we hope to explore the kinetics of its “turn-on”
fluorescence and self-immolative drug release.
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Scheme 1. Synthesis of Rhodamine Dye3,4
Figure 8. Material added through 
side arm of bomb flask. 
(CHEMGlass, 2020)
Figure 7. Solvent system gradient used 
for better separation. (Copyscape, 2018)
• Changed molar equivalents
• Used solvent system gradient
• Dissolved material in solvent, then inserted through side arm of flask 
• Skipped addition of second protecting group and went straight to 
nitro reduction
• Utilized Prep TLC Technique
Optimizing Reactions
In small molecule theranostics, the focus is to integrate a type of diagnostic testing to
observe the presence of a drug in the desired molecular target. This method
provides a non-invasive technique in detecting things such as diseases.1 In previous
designs, linkers served the sole purpose of bridging the trigger and drug together
and activating a cascade of disassembly reactions.2 Our goal is to optimize the use
of a linker by serving both it’s original purpose, as well as providing a fluorescence
response followed by a release of a drug. Rhodamine dyes have shown promising
characteristics as a linker due to its electron rich ring which provides a mechanism of
action for a fluorescent turn on and drug release. The synthesis of our desired
rhodamine dye has yet to be studied. It is our hope, through this research, to be
able to optimize the use of linkers and control the self-immolative effects of the dye
which will improve the ways we analyze the effectiveness of drugs today. • Complete synthesis of rhodamine core
• Optimize nitro reduction & addition of second protecting group
• Use NMR and UV-Vis Spectroscopy to test the molecular logic and 
kinetics of the compound
• Study cell-based assays utilizing proposed rhodamine dye  
• Synthesized an advanced precursor of desired rhodamine dye
• Optimized the bromination step through modifying the way the starting 
material was added into the bomb flask
Proposed Mechanism of Dye Formation
Scheme 2. Mechanism of Rhodamine Dye
Figure 4. Mechanism to ”turn on” fluorescent dye Figure 5. Mechanism of drug release
Figure 2. Illustration of basic 
self-immolative structure of proposed design
Figure 3. Illustration of self-immolative structure 
with desired rhodamine dye linker
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